FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Industry Outlines Overall MDUFA 5 Proposal

Just-released minutes describe industrys overall proposal for the MDUFA 5 agreement.

Human Drugs

Variable Clinical Pharmacology Studies for Peptides Needed: Merck

Merck calls on FDA to consider using a variety of methods to assess clinical pharmacology for peptides.

Medical Devices

FDA Accepts Invivos 1st Neuro-Spinal Scaffold HDE Module

FDA accepts the first HDE module submitted by Invivo for its Neuro-Spinal Scaffold implant.

Human Drugs

Halodine Marketing Covid-19 Unapproved New Drugs: FDA

FDA warns Halodine it is marketing unapproved and misbranded non-alcohol-based antiseptic products for Covid-19.

Biologics

FDA, J&J Mull Guillain-Barré Warning on Vaccine

Johnson & Johnson discusses with FDA and other regulators rare cases of Guillain-Barré syndrome that have been reported following vaccination wi...

Biologics

Q & A Guide on Cell/Tissue Product Enforcement

FDA posts a guidance that answers common questions about the end of the compliance and enforcement policy for certain human cells, tissues, or cellula...

Federal Register

Notice Corrected on 2 ANDA Withdrawals

Federal Register notice: FDA corrects a 12/2/2019 notice announcing the withdrawal of 21 ANDAs from multiple applicants.

Biologics

Janssens Darzalex Faspro OKd for Multiple Myeloma

FDA approves a Janssen Biotech BLA for Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with pomalidomide and dexamethasone for cer...

Medical Devices

Magellan Diagnostics Recalls Lead Tests

Magellan Diagnostics recalls its LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests due to a significant risk of false low results.

Medical Devices

Avanos Pays $22 Million Over Misbranded Device

Avanos Medical agrees to pay more than $22 million to resolve a criminal charge relating to the companys fraudulent misbranding of its MicroCool surgi...